Up to 7% (developed world), up to 30% (developing world)[1]
Giardiasis is aparasitic disease caused by theprotist enteropathogenGiardia duodenalis (also known asG. lamblia andG. intestinalis), especially common in children and travelers.[3][4] Infected individuals experiencesteatorrhea, a type ofdiarrhea with fatty sticky stool;abdominal pain,weight loss, and weakness due todehydration andmalabsorption.[1] Less common symptoms include skin rash,hives andjoint swelling.[1] Symptoms usually begin one to three weeks after exposure and, without treatment, may last two to six weeks or longer.[5] Some infected individuals experience mild or no symptoms and remain symptom-free even if the infection persists for a long time.[6]
Giardiasis spreads via thefecal-oral route, whenGiardia cysts excreted with feces contaminate food or water that is later consumed orally.[1] The disease can also spread between people and between people and animals, mainly via pets.[1][7][8] Cysts may survive for nearly three months in cold water.[1]
The microscopic identification of Giardia and its cysts in fecal samples is considered the gold standard method for diagnosing giardiasis.[9] Immunoassays, such asELISA andPCR for giardia gene loci, are also available as diagnostic tools, although are not widely used due to methods complexity and costs.[9]
Prevention may be improved through proper personalhygiene practices and by cooking and sanitizing food.[1] Asymptomatic cases often do not need treatment. When symptoms are present, treatment is typically provided with eithertinidazole ormetronidazole.[1] Other drugs, such asnitazoxanide,albendazole,quinacrine,chloroquine,paromomycin, and other drug combinations are also used in clinics.[10] Refractory giardiasis and resistant strains are reported more and more often.[11] Infection may cause a person to becomelactose intolerant, so it is recommended to temporarily avoidlactose following an infection or uselactase supplements.[1]
Giardiasis occurs worldwide.[12] It is one of the most commonparasitic human diseases.[3] Infection rates are as high as 7% in thedeveloped world and 30% in thedeveloping world.[1] In 2013, there were approximately 280 million people worldwide with symptomatic cases of giardiasis.[3] The World Health Organization classifies giardiasis as aneglected disease.[1] It is popularly known asbeaver fever[13] in North America.
The signs and symptoms vary from none to severe diarrhoea with poor nutrient absorption.[12] The cause of this wide range in severity of symptoms is not fully known, but the intestinal flora of the infected host may play a role.[14][15] Diarrhoea is less likely to occur in people from developing countries.[14]
Symptoms typically develop 9–15 days after exposure,[16] but may occur as early as one day.[12] The most common and prominent symptom is chronic diarrhoea, which can occur for weeks or months if untreated.[17][18] Diarrhoea is often greasy and foul-smelling, with a tendency to float.[17][5] This characteristic diarrhoea (steatorrhea) is often accompanied by several other symptoms, includinggas, abdominal cramps, and nausea or vomiting.[17][5] Some people also experience symptoms outside of the gastrointestinal tract, such as itchy skin,hives, and swelling of the eyes and joints, although these are less common.[5] Fever occurs in only about 15% of infected people,[19] despite the nickname "beaver fever".[13]
Giardiasis is caused by theprotozoanGiardia duodenalis.[23] The infection occurs in many animals, including pets, beavers, other rodents, cows, and sheep.[23] Animals are believed to play a role in keeping infections present in an environment.[23]
G. duodenalis has been sub-classified into eight genetic assemblages (designated A–H).[7] Genotyping ofG. duodenalis isolated from various hosts has shown that assemblages A and B infect the largest range of host species, and appear to be the main and possibly onlyG. duodenalis assemblages that infect humans.[7][24]
People who are in close contact with someone who has the disease
Travellers within areas that have poor sanitation
People who have contact with faeces, such as during sexual activity
Backpackers or campers who drink untreated water from springs, lakes, or rivers
Swimmers who swallow water from swimming pools, hot tubs, interactive fountains, or untreated recreational water from springs, lakes, or rivers
People who get their household water from a shallow well
People with weakened immune systems
People who have contact with infected animals or animal environments contaminated with faeces
Factors that increase infection risk for people from developed countries include changing nappies/diapers, consuming raw food, owning a dog, and travelling in thedeveloping world.[1] However, 75% of infections in the United Kingdom are acquired in the UK, not through travel elsewhere.[1] In the United States, giardiasis occurs more often in summer, which is believed to be due to a greater amount of time spent on outdoor activities and travelling in the wilderness.[23]
Giardiasis is transmitted via thefaecal-oral route with the ingestion ofcysts.[16] Primary routes are personal contact and contaminated water and food.[16] The cysts can stay infectious for up to three months in cold water.[23] Both symptomatic andasymptomatic carriers excrete cysts and thus spread the disease.[26]
The life cycle ofGiardia consists of a cyst form and a trophozoite form.[15] The cyst form is infectious and once it has found a host, it transforms into the trophozoite form.[15] This trophozoite attaches to the intestinal wall and replicates within the gut.[15] As trophozoites continue along the gastrointestinal tract, they convert back to their cyst form, which is then excreted with faeces.[1] Ingestion of only a few of these cysts is needed to generate infection in another host.[27]
Infection withGiardia results in decreased expression ofbrush border enzymes, morphological changes to themicrovillus, increased intestinal permeability, andprogrammed cell death of small intestinalepithelial cells.[28] Both trophozoites and cysts are contained within the gastrointestinal tract and do not invade beyond it.[29]
The attachment oftrophozoites causes villous flattening and inhibition ofenzymes that break down disaccharide sugars in the intestines.[14][28] Ultimately, thecommunity of microorganisms that lives in the intestine may overgrow and may be the cause of further symptoms, though this idea has not been fully investigated. The alteration of the villi leads to an inability of nutrient andwater absorption from the intestine, resulting in diarrhoea, one of the predominant symptoms.[28] In the case of asymptomatic giardiasis, there can be malabsorption with or without histological changes to the small intestine. The degree to which malabsorption occurs in symptomatic and asymptomatic cases varies greatly.[citation needed]
The speciesGiardia intestinalis usesenzymes that break down proteins to attack the villi of the brush border and appears to increase crypt cell proliferation and crypt length of crypt cells existing on the sides of the villi. On an immunological level, activated hostT lymphocytes attack endothelial cells that have been injured to remove the cells.[14] This occurs after the disruption of proteins thatconnect brush border endothelial cells to one another.[28] The result is increased intestinal permeability.[28]
There appears to be a further increase in programmed enterocyte cell death byGiardia intestinalis, which further damages the intestinal barrier and increases permeability.[28] There is significant upregulation of the programmed cell death cascade by the parasite, and substantial downregulation of the anti-apoptotic proteinBcl-2 and upregulation of the proapoptotic proteinBax.[14] These connections suggest a role ofcaspase-dependent apoptosis in the pathogenesis of giardiasis.[14]
Giardia protects its growth by reducing the formation of the gasnitric oxide by consuming all localarginine, which is theamino acid necessary to make nitric oxide.[14] Arginine starvation is known to be a cause of programmed cell death, and local removal is a strong apoptotic agent.[30]
Giardia lamblia evades host immunity through antigenic variation of its variant-specific surface proteins (VSPs).Giardia’s trophozoite genome contains more than 200 VSPs, but only one VSP is displayed on the trophozoite’s surface at any given time.[31][32] RNA interference (RNAi) suppresses all but one VSP mRNA, which results in only one VSP being expressed on the surface of the trophozoite.[32]
When switching occurs the previously expressed VSP disappears and a different VSP mRNA bypasses the RNAi suppressing and results in the expression of the new VSP on the trophozoites surface allowing the parasite to evade immunity.[32]
Host defence againstGiardia consists of natural barriers, production of nitric oxide, and activation of the innate and adaptive immune systems.[citation needed]
Natural barriers defend against the parasite entering the host's body. Natural barriers consist ofmucus layers, bile salt,proteases, andlipases. Additionally,peristalsis and the renewal ofenterocytes provide further protection against parasites.[33][34]
The lectin pathway of complement is activated by mannose-binding lectin (MBL), which binds to N-acetylglucosamine. N-acetylglucosamine is a ligand for MBL and is present on the surface ofGiardia.[37]
Antibodies inhibit parasite replication and also induce parasite death via the classical pathway of complement.[citation needed]
Infection withGiardia typically results in a strong antibody response against the parasite. While IgG is made in significant amounts, IgA is believed to be more important in parasite control. IgA is the most abundant isotype in intestinal secretions, and it is also the dominant isotype in a mother's milk. Antibodies in a mother's milk protect children against giardiasis (passive immunisation).[38]
The major aspect of adaptive immune responses is theT-cell response.Giardia is an extracellular pathogen. Therefore, CD4+ helper T-cells are primarily responsible for this protective effect.[39]
One role of helper T-cells is to promote antibody production and isotype switching. Other roles include cytokine production (IL-4, IL-9) to help recruit other effector cells of the immune response.[39][40]
A duodenal biopsy may incidentally detectGiardia organisms, as in thisH&E stained sample.[41]
According to the CDC, the detection of antigens on the surface of organisms in stool specimens is the current test of choice for the diagnosis of giardiasis and provides increased sensitivity over more common microscopy techniques.[42]
A trichrome stain of preserved stool is another method used to detectGiardia.[43]
Microscopic examination of the stool can be performed for diagnosis.[1] This method is not preferred, however, due to inconsistent shedding of trophozoites and cysts in infected hosts.[1] Multiple samples over some time, typically one week, must be examined.[1]
TheEntero-Test uses a gelatin capsule with an attached thread. One end is attached to the inner aspect of the host's cheek, and the capsule is swallowed. Later, the thread is withdrawn and shaken in saline to release trophozoites, which can be detected with a microscope. The sensitivity of this test is low, however, and is not routinely used for diagnosis.[44]
Immunologic enzyme-linked immunosorbent assay (ELISA) testing may be used for diagnosis.[45] These tests are capable of a 90% detection rate or more.[45]
Althoughhydrogen breath tests indicate poorer rates of carbohydrate absorption in those asymptomatically infected, such tests are not diagnostic of infection.[46] Serological tests are not helpful in diagnosis.[1]
The CDC recommends hand-washing and avoiding potentially contaminated food and untreated water.[47]
Boiling water contaminated withGiardia effectively kills infectious cysts.[48] Chemical disinfectants or filters may be used.[49][50] Iodine-based disinfectants are preferred over chlorination as the latter is ineffective at destroying cysts.[51][52]
Although the evidence linking the drinking of water in the North American wilderness and giardiasis has been questioned, several studies raise concerns.[53] Most if not all CDC verified backcountry giardiasis outbreaks have been attributed to water. Surveillance data (for 2013 and 2014) reports six outbreaks (96 cases) of waterborne giardiasis contracted from rivers, streams or springs[54] and less than 1% of reported giardiasis cases are associated with outbreaks.[55]
Person-to-person transmission accounts for the majority ofGiardia infections and is usually associated with poor hygiene and sanitation.Giardia is often found on the surface of the ground, in the soil, in undercooked foods, and in water, and on hands that have not been properly cleaned after handling infectedfaeces.[56] Water-bornetransmission is associated with the ingestion of contaminated water. In the U.S., outbreaks typically occur in small water systems using inadequately treated surface water.Venereal transmission happens through faecal-oral contamination. Additionally, nappy/diaper changing and inadequate handwashing are risk factors for transmission from infected children. Lastly, food-borne epidemics ofGiardia have developed through the contamination of food by infected food handlers.[57]
There are no vaccines for humans; however, several vaccine candidates are in development. They are targeting: recombinant proteins, DNA vaccines, variant-specific surface proteins (VSP), cyst wall proteins (CWP), giadins, and enzymes.[58] Researchers atCONICET have produced an oral vaccine after engineering customised proteins mimicking those expressed on the surface of Giardia trophozoites. The vaccine has proven effective in mice.[59][60]
One commercially available vaccine exists – GiardiaVax, made fromG. lamblia whole trophozoite lysate. It is a vaccine for veterinary use only in dogs and cats. GiardiaVax should promote the production of specific antibodies.[61]
Treatment is not always necessary as the infection usually resolves on its own.[14] However, if the illness is acute or symptoms persist and medications are needed to treat it, anitroimidazole medication is used such asmetronidazole,tinidazole,secnidazole orornidazole.[16]
TheWorld Health Organisation andInfectious Disease Society of America recommend metronidazole as first-line therapy.[62][63] TheUS CDC lists metronidazole, tinidazole, andnitazoxanide as effective first-line therapies;[64] of these three, only nitazoxanide and tinidazole are approved for the treatment of giardiasis by the USFDA.[65][66][67] A meta-analysis published by theCochrane Collaboration in 2012 found that compared to the standard of metronidazole,albendazole had equivalent efficacy while having fewer side effects, such as gastrointestinal or neurologic issues.[68] Other meta-analyses have reached similar conclusions.[69] Both medications need a five to ten-day-long course; albendazole is taken once a day, while metronidazole needs to be taken three times a day. The evidence for comparing metronidazole to other alternatives such as mebendazole, tinidazole, or nitazoxanide was felt to be of very low quality.[68] While tinidazole has side effects and efficacy similar to those of metronidazole, it is administered with a single dose.[26]
Resistance has been observed clinically to both nitroimidazoles and albendazole, but not nitazoxanide, though nitazoxanide resistance has been induced in research laboratories.[27][70] The exact mechanism of resistance to all of these medications is not well understood.[70] In the case of nitroimidazole-resistant strains ofGiardia, other drugs are available which have shown efficacy in treatment includingquinacrine, nitazoxanide,bacitracin zinc,furazolidone andparomomycin.[26]Mepacrine may also be used for refractory cases.[27]
Probiotics, when given in combination with the standard treatment, have been shown to assist with clearance ofGiardia.[71]
During pregnancy, paromomycin is the preferred treatment drug because of its poor intestinal absorption, resulting in less exposure to the foetus.[72] Alternatively, metronidazole can be used after the first trimester as there has been wide experience in its use fortrichomonas in pregnancy.[26][73]
In people with a properly functioning immune system, infection may resolve without medication.[14] A small portion, however, develop a chronic infection.[14] People with an impaired immune system are at higher risk of chronic infection.[14] Medication is an effective cure for nearly all people, although there is growing drug resistance.[1][74][27]
Children with chronic giardiasis are at risk for failure to thrive as well as more long-lasting sequelae such as growth stunting.[75] Up to half of infected people develop a temporarylactose intolerance leading to symptoms that may mimic a chronic infection.[1] Some people experience post-infectiousirritable bowel syndrome after the infection has cleared.[14] Giardiasis has also been implicated in the development offood allergies.[14] This is thought to be due to its effect on intestinal permeability.[14]
In somedeveloping countriesGiardia is present in 30% of the population.[23] In the United States it is estimated that it is present in 3–7% of the population.[23] Giardiasis is associated with impaired growth and development in children, particularly influencing a country's economic growth by affecting Disability Adjusted Life Year (DALY) rates.[31][76]
The number of reported cases in the United States in 2018 was 15,584.[77] All states that classify giardiasis as a notifiable disease had cases of giardiasis.[77] The states of Illinois, Kentucky, Mississippi, North Carolina, Oklahoma, Tennessee, Texas, and Vermont did not notify the Centers for Disease Control and Prevention regarding cases in 2018.[77] There are seasonal trends associated with giardiasis.[78] July, August, and September are the months with the highest incidence of giardiasis in the United States.[79]
In the ECDC's (European Centre for Disease Prevention and Control) annual epidemiological report containing 2014 data, 17,278 confirmed giardiasis cases were reported by 23 of the 31 countries that are members of the EU/EEA.[80] Germany reported the highest number at 4,011 cases.[80] Following Germany, the UK reported 3,628 confirmed giardiasis cases. Together, this accounts for 44% of total reported cases.[80]
Some intestinal parasitic infections may play a role inirritable bowel syndrome[81] and other long-term sequelae such as chronic fatigue.[82][83] The mechanism of transformation from cyst to trophozoites has not been characterised[15] but may help develop drug targets for treatment-resistantGiardia. The interaction betweenGiardia and host immunity, internal flora, and other pathogens is not well understood.[14]In vitro cell cultures have been widely used to study host-parasite interactions, and human enteroids are now being used as non-transformed intestinal epithelial cell infection models for G. intestinalis and other pathogens.[84]
The main congress about giardiasis is the "International Giardia and Cryptosporidium Conference" (IGCC). A summary of results presented at the most recent edition (2019, inRouen, France) is available.[85]
In both cats and dogs, giardiasis usually responds to metronidazole and fenbendazole. Metronidazole in pregnant cats can cause developmental malformations.[86] Many cats dislike the taste of fenbendazole.[86] Giardiasis has been shown to decrease weight in livestock.[14]
^abc"Giardiasis".cdc.gov. December 9, 2017.Archived from the original on April 14, 2021. Retrieved27 March 2022.
^ab"Giardiasis (beaver fever)". New York State Department of Health. January 2022.Archived from the original on 20 January 2022. Retrieved27 March 2022.
^abcdBarry MA, Weatherhead JE, Hotez PJ, Woc-Colburn L (April 2013). "Childhood parasitic infections endemic to the United States".Pediatric Clinics of North America.60 (2):471–85.doi:10.1016/j.pcl.2012.12.011.PMID23481112.
^abcdefDespommier DD, Griffin DO, Gwadz RW, Hotez PJ, Knirsch CA."III. Eukaryotic Parasites".Parasitic Diseases (6 ed.). NY: Parasites Without Borders. pp. 11–17. Archived fromthe original on 7 March 2020. Retrieved11 July 2018.
^abcRobertson LJ, Hanevik K, Escobedo AA, Mørch K, Langeland N (February 2010). "Giardiasis--why do the symptoms sometimes never stop?".Trends in Parasitology.26 (2):75–82.doi:10.1016/j.pt.2009.11.010.PMID20056486.
^abRosenblatt JE, Sloan LM, Schneider SK (May–June 1993). "Evaluation of an enzyme-linked immunosorbent assay for the detection of Giardia lamblia in stool specimens".Diagnostic Microbiology and Infectious Disease.16 (4):337–41.doi:10.1016/0732-8893(93)90086-M.PMID8495591.
^Betancourt WQ, Rose JB (December 2004). "Drinking water treatment processes for removal of Cryptosporidium and Giardia".Veterinary Parasitology.126 (1–2):219–34.doi:10.1016/j.vetpar.2004.09.002.PMID15567586.
^Exner M, Gornik V (July 2004). "[Parasitic zoonoses transmitted by drinking water. Giardiasis and cryptosporidiosis]".Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.47 (7):698–704.doi:10.1007/s00103-004-0863-y.PMID15254826.
^Dunn, Noel; Juergens, Andrew L. (2019),"Giardiasis",StatPearls, StatPearls Publishing,PMID30020611, retrieved2019-10-31
^"Giardia: Treatment". United States Centers for Disease Control and Prevention. 21 July 2015.Archived from the original on 24 December 2015. Retrieved10 January 2016.Several drugs can be used to treat Giardia infection. Effective treatments include metronidazole, tinidazole, and nitazoxanide1. Alternatives to these medications include paromomycin, quinacrine, and furazolidone1,2.
^Kasper, Dennis L.; Larry Jameson, J.; Hauser, Stephen L.; Loscalzo, Joseph; Fauci, Anthony S.; Longo, Dan L. (2015-04-08).Harrison's principles of internal medicine. Kasper, Dennis L.,, Fauci, Anthony S., 1940-, Hauser, Stephen L.,, Longo, Dan L. (Dan Louis), 1949-, Jameson, J. Larry,, Loscalzo, Joseph (19th ed.). New York.ISBN978-0-07-180215-4.OCLC893557976.{{cite book}}: CS1 maint: location missing publisher (link)
^Painter, Julia E.; Gargano, Julia W.; Collier, Sarah A.; Yoder, Jonathan S. (2015-05-01). "Giardiasis surveillance -- United States, 2011-2012".MMWR Supplements.64 (3):15–25.ISSN2380-8942.PMID25928582.
^Jonathan S. Yoder, MPH; Julia W. Gargano, PhD; Ryan M. Wallace, DVM; Michael J. Beach, PhD (2012)."Giardiasis Surveillance-United States, 2009-2010".Morbidity and Mortality Weekly Report. Surveillance Summaries.61 (5). Centers of Disease Control and Prevention:13–23.PMID22951494. Retrieved30 November 2017.
^Stark D, van Hal S, Marriott D, Ellis J, Harkness J (January 2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis".International Journal for Parasitology.37 (1):11–20.doi:10.1016/j.ijpara.2006.09.009.PMID17070814.
